39 results on '"Stelloo, Ellen"'
Search Results
2. Abstract 222: High frequency of structural variants in FFPE colorectal cancer tissue detected by targeting selected common fragile site genes and LINE transposable elements
3. Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
4. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
5. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
6. Supplementary figure 6 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
7. Supplementary figure 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
8. Supplementary Table S5 from Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
9. Supplementary figure 4 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
10. Supplementary table 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
11. Figure S4 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
12. Figure S2 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
13. Figure S7 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
14. Figure S3 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
15. Figure S1 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
16. Supplementary figure 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
17. Figure S3 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
18. Supplementary figure 5 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
19. Figure S6 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
20. Supplementary figure 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
21. Supplementary figure 5 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
22. Supplementary figure 3 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
23. Figure S5 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
24. Supplementary figure 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
25. Figure S5 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
26. Supplementary figure 3 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
27. Figure S6 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
28. Figure S7 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
29. Figure S4 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
30. Supplementary table 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
31. Supplementary figure 6 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
32. Figure S1 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
33. Figure S2 from Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
34. Supplementary figure 4 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
35. Abstract A020: Structural variants in the pathogenesis of colorectal cancer: The elephant in the room
36. Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
37. Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma
38. Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts
39. POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.